Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Honey
You have no idea if what’s going on in what you call as third world countries like India. The best hospitals out there are already using Da Vinci! Must of them reconditioned from previous generations and out to good use. Their doctors are smarter than the ones here as they know how to get the best at the lowest price!!!
Anybody knows of the CAOG conference going on right now on Napa CA? Someone is talking about Titan, Verb, Flex Medtronics etc aa I write this.
Thanks
Read the filing - if no need for reverse split then why include in the filing
Check this filing
https://stocktwits.com/Newsfilter/message/311348675
What’s the chance of a reverse split coming this year. That’s what the filling seems to suggest. Anywhere from 1:4 to 1:20. How will that impact SP in the short run?
It’s not not he does know how to increase SP, he just does not want to do it for obvious reasons. Don’t expect any help from McNally to increase SP
I never believed and still don’t believe the BO story. If anyone bought TMDI based on the BO story they are gambling and not investing.
What is Ocugen’s role in Covaxin, as it’s being developed by Bharati biotec in India
What’s the role of OCGN in the Indian vaccine - Covaxin? I thought it was developed in India but then I see this company in Maryland saying they are co-developers?
Great synopsis of TMDI
Someone pointed that out in a previous post and I think it’s a very important point to know. Titan’s technology and patents are great but they are not worth much of Titan cannot get their act together very soon. There are new players and technologies coming into the market all the time and Titan has and will continue to loose its technological advantage/superiority over them - all because of the years that have been lost due to incompetent management and it’s games.
Ten years ago it was Da Vinci and Titan - now look at the competition with equally good technology and far better financial, regulatory, and administrative support. Titan knows that it has been left behind in the competition but cannot admit it for obvious reasons. Otherwise who would sell such technology to Medtronics in bits and pieces - like spares in a junkyard. Sorry for the harsh rhetoric but I am just narrating my experience with TMDI. And thank you all who helped raise the pps as it could cut my losses.
You, like many others of this board, are too abundant with optimism and speculation that you cannot read the writing as it is. For a moment look at things the way they are and you might develop another perspective.
Every time in the past that pps started to rise without reason or news it has led to a new round of offering. The rise of pps and announcement about FDA was intended all indicated another round of dilution. It was so obvious but you could not see it coming because you are very optimistic.
Titan’s technology is great and it may turn out to be profitable but one should never lose sight of how this company operates. Until a BO happens (if it ever does) this company is the chicken that will keep laying golden eggs for the managers through dilution. That’s how they keep their jobs!!
That is the difference between the two companies - TMDI has bad leadership. That they haven’t been able to get the robot ready for FDA after all these years is the proof. All they do is raise money and push forth the milestones. This company is their cash cow and they cannot milk it enough - all at the cost of shareholders.
Was the leadership of ISRG ever as bad and opaque as that of Titan?
There are two things that indicate the value of a company - share price action and the company performance. TMDIs performance as a company is way short of what an efficient startup looks like. TMDIs share price action is a scam. When you put the two together it stinks, and it has done so for the last 10 years.
Stop kidding yourself about TMDI - this one is nothing else but a cash cow for it’s managers and executives. Even if it gets BO it be will be at price much lower than it’s worth that most of retail share holders won’t make anything after being invested for years.
This is a great stock to profit from if you can understand TMDIs share price action without being over zealous about its long term prospects - as there aren’t any!!!!
Do you mean 12/15/29 or 12/15/20? Funny you say that.
Retrospectively - all boards in the last 10 years were useless and clueless, not because they were stupid or euphoric but just because they did not know what they were up against. TMDI board members are generally well meaning and believe that their company will do the right thing. Unfortunately they don’t know the history of Titan and what a scam it has been made into by the people who are in charge
I don’t remember how many times the board asked the same question in the last 10 years.
Honeycomb .... you nailed it. That’s the truth and some of us long timers know it. I cannot believe that Titan has not fixed the final robot and gone in for FDA after 10 years - just goes to show how badly it is run by those in charge. I will be pleasantly surprised if the Medtronic deal turns out to be anything but an eyewash.
This is not the first time TMDI has increased in price without a reason or has fallen down in price without any explanation. I have been invested in this company for over 10 years and have seen the exuberance and the despair that board members display - the only change I notice is that new members show up and old babes vanish after a few months. Good luck to all of you.
You are very welcome.
Check this out, mentions Titan: Global Medical Robotics and Computer - Assisted Surgery (MRCAS) Market (Equipments, Applications, Geography)
www.mynewsdesk.com
I agree with some of the things you say, but this is a public forum and you are going to get all sorts of folks here - some with genuine concerns and honest contributions to make and others with their own (hidden) agendas. That's just the nature of this beast.
I am invested in Titan for over two years now and will stay invested until the company exists because I believe in the product. Naysayers don't bother me and I am willing to lose all my investment in this company because of my belief and knowledge of MIS. In fact every naysayer has the potential to make me more money as I can buy more shares at a low price.
If you look at it that way you too will profit more. Be happy that we have some such naysayers and bashers amongst us. Don't be insecure.
Have a good rest of the evening
ORep....members on this board have a right to vent their frustrations even if you don't like that or agree with them. Why are you asking them to shut up? Instead why don't you learn to ignore them.
Totally agree.
I am inclined to agree with you. There are so many moving parts here that it is beyond our comprehension to know what is going on in the background. Many on this board have been prematurely focussed on pps and other matters relating to that. We are right now in the phase of technology improvement and product finalisation - no point in putting the cart ahead of the horse!
I dont like to see the pps going down, but frankly, the mayhem that is going on right now could turn out to be one of the best opportunities to make big money. I have enough shares to be content with, but if the price goes down to as low as some people have speculated I will be loading my boat!!!!!
That just goes to show that we are dealing with a complex technology and we need to be patient at this stage. The news on friday may not even be the last of the hiccups, we must just be ready to deal with such issues. Besides making money there has to be a larger objective - and that is the joy of being a part of a truly marvelous process of growth and contribution to medicine.
I will not sell my shares as I thrive in my life because of the immense joy in being associated with the development of something as disruptive as SPORT. I can make money somewhere else!
Here is the whole story. This company at one point in time (and probably still) was partnering with ISRG to provide staplers for their MIS. Their product is actually quite promising but has not had the impact it was thought it would. If they succeed they can break into a market that is billions of dollars .............
BusinessWire, GlobeNewswire and PR Newswire News
Cardica Inc CRDC:NASDAQ
Cardica Announces Shift In Focus
PR Newswire
8:00 AM ET
Cardica, Inc. (Nasdaq: CRDC) today announced that the Cardica Board has approved management's recommendation to shift Cardica's primary focus from its controlled commercial launch of the MicroCutter XCHANGE(R) 30 surgical stapler to improving its performance prior to a broad commercial launch. As a result, Cardica has temporarily suspended the controlled commercial launch and is voluntarily withdrawing its latest iteration of the MicroCutter XCHANGE 30 surgical stapler from the market (approximately 220 units) with the intention to replace them with the next generation of the MicroCutter XCHANGE 30 surgical stapler when completed. Cardica expects surgeons to continue to use the standard MicroCutter XCHANGE 30 surgical stapler (approximately 100 units) remaining in the field but has no plans to manufacture additional standard units due to changes in the supply chain.
Cardica initiated the controlled commercial launch to obtain feedback from surgeons on the performance of the MicroCutter XCHANGE 30. Cardica's goal is to accelerate product improvements on the MicroCutter XCHANGE 30 before executing a broad commercial launch. The Cardica Board is committed to creating value for its stockholders by achieving the full potential of Cardica's cutting edge technology and this shift in focus is intended to optimize the capabilities of the MicroCutter XCHANGE 30.
The Board and management are reexamining Cardica's operations to focus on conserving cash by aligning spending with its focused plan going forward. After further analysis of Cardica's operations, including timing and budget, Cardica will provide an update to stockholders.
About CardicaCardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter XCHANGE 30, a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter, is manufactured and cleared for use in a variety of gastrointestinal procedures and appendectomies in the United States, and is marketed for a wide range of surgical procedures in Europe. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port(R) Distal Anastomosis Systems and PAS- Port(R) Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 52,000 units throughout the world.
To learn more about Cardica, please visit Cardica's website at www.cardica.com.
Forward-Looking Statements
The statements in this press release relating to Cardica's ability to improve the performance of the MicroCutter XCHANGE 30 surgical stapler for broad commercial launch and the ability of Cardica to align its spending with its future plans are "forward-looking statements." There are a number of important factors that could cause results to differ materially from those indicated by these forward-looking statements, including: unexpected technical difficulties may arise in the improvements of the MicroCutter XCHANGE 30 which may delay or prevent the broad commercialization of the MicroCutter XCHANGE 30; as well as other risks detailed from time to time in Cardica's reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, under the caption "Risk Factors," filed on November 12, 2014. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. Readers are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.
SOURCE Cardica, Inc.
Did you see what Cardica, which makes small diameter staplers announced today as their products have failed even after regulatory approvals. It TITAN decides to change its course of product development at this stage then what is the harm?
Cardica, Inc. (Nasdaq: CRDC) today announced that the Cardica Board has approved management's recommendation to shift Cardica's primary focus from its controlled commercial launch of the MicroCutter XCHANGE(R) 30 surgical stapler to improving its performance prior to a broad commercial launch. As a result, Cardica has temporarily suspended the controlled commercial launch
my guess is that they could know about this only after the prototypes were shares with the stakeholders/end users. My other guess is that they learnt about it relatively recently. Once again, I am must clarify, that I am assuming that nothing fishy is going on, and that design development is not a cover-up for something else.
I am an architect, and have worked extensively in areas of product development and technology implementation, including human interface development. I am also a professor of design.
Machines, devices, buildings, technologies are like human beings. You never know what one may excel in.
A system or product (after it is designed and brought out into the market) takes a life of its own, and finds itself uses that it was not originally meant for. There is nothing wrong in that. Its like technology, it may be developed with something in mind, but eventually turns out that it also has other, and often, better applications that what it was originally designed for.
In short, real designers, engineers and scientists dont like to close their mind to possibilities! I think that is what is going on at Titan, unless there is something that we dont know.
I tend to agree with you md20. They could have come out with an underdeveloped device or one with limited application. But then it won't sell and the situation would be worse due to losses that would affect the pps. I have seen medical devices companies come out with finished products and even get FDA clearances, only to find out that there is no real application for their device and therefore no market. I prefer spending more time now than coming out with something that is not better or even comparable with da vinci.
Physical modelling or prototyping is now increaisngly replaced by 3d printing. That is the way design of physical products, instruments and buildings are developed. Goes on for a long time and many prototypes are developed, some of them are simulated on softwares like autocad.
Thank you.
Prove to whom? To You? Why?
ORep8
I dont doubt elcaribes information. I believe in human honesty and integrity until I have a reason not to. At the same time I dont need any verifications (like screen shots etc) to trust or not trust someone on this board.
In the same vein I dont think it is necessary for me to provide any more details than what I wish to. Therefore, I am sorry, I cannot provide you screenshots or anything else. As I said in my earlier message 'if you wish to use my information please do it at your own risk'.
My information is about an hour old. I am sharing with this board because I have learnt a lot from everybody and benefitted from the collective knowledge/wisdom on this board. I am a long term investor like many on this board.
Anybody who wishes to use this information please do it at your own risk.
Good guess